Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1976 Sep;25(3):383–388.

A membrane-associated autoantibody in a case of myasthenia gravis with chronic hepatitis.

A J Fairfax, D Doniach, C E Wells
PMCID: PMC1541407  PMID: 786517

Abstract

A new antibody reacting with a cell membrane-related antigen is described in a patient with myasthenia gravis and chronic liver disease. The antibody gave a striking peripheral immunofluorescence in all cells tested and did not react with smooth muscle fibres, being distinct from anti-actin and anti-myosin antibodies. The antigen was widely distributed in human and animal tissues. The exact relationship of this antibody to the clinical condition is not obvious but its presence is further evidence of widespread disturbances of humoral immunity in myasthenia gravis.

Full text

PDF
383

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALARCON SEGOVIA D., GALBRAITH R. F., MALDONADO J. E., HOWARD F. M., Jr SYSTEMIC LUPUS ERYTHEMATOSUS FOLLOWING THYMECTOMY FOR MYSTHENIA GRAVIS. REPORT OF TWO CASES. Lancet. 1963 Sep 28;2(7309):662–665. doi: 10.1016/s0140-6736(63)90456-2. [DOI] [PubMed] [Google Scholar]
  2. Beck M. L., Butch S. H., Armstrong W. D., Oberman H. A. An autoantibody with U-specificity in a patient with myasthenia gravis. Transfusion. 1972 Jul-Aug;12(4):280–283. doi: 10.1111/j.1537-2995.1972.tb00048.x. [DOI] [PubMed] [Google Scholar]
  3. Bender A. N., Ringel S. P., Engel W. K., Daniels M. P., Vogel Z. Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction. Lancet. 1975 Mar 15;1(7907):607–609. doi: 10.1016/s0140-6736(75)91886-3. [DOI] [PubMed] [Google Scholar]
  4. Biberfeld G., Fagraeus A., Lenkei R. Reaction of human smooth muscle antibody with thyroid cells. Clin Exp Immunol. 1974 Nov;18(3):371–377. [PMC free article] [PubMed] [Google Scholar]
  5. Bottazzo G. F., Florin-Christensen A., Fairfax A., Swana G., Doniach D., Groeschel-Stewart U. Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol. 1976 May;29(5):403–410. doi: 10.1136/jcp.29.5.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Engel W. K., Festoff B. W., Patten B. M., Swerdlow M. L., Newball H. H., Thompson M. D. Myasthenia gravis. Ann Intern Med. 1974 Aug;81(2):225–246. doi: 10.7326/0003-4819-81-2-225. [DOI] [PubMed] [Google Scholar]
  7. Gabbiani G., Ryan G. B., Lamelin J. P., Vassalli P., Majno G., Bouvier C. A., Cruchaud A., Lüscher E. F. Human smooth muscle autoantibody. Its identification as antiactin antibody and a study of its binding to "nonmuscular" cells. Am J Pathol. 1973 Sep;72(3):473–488. [PMC free article] [PubMed] [Google Scholar]
  8. Horne C. H., Briggs R. D., Nicol A. G., Hopkins L. M. Letter: Thyroid-cell-membrane antibodies. Lancet. 1975 Aug 30;2(7931):411–412. doi: 10.1016/s0140-6736(75)92928-1. [DOI] [PubMed] [Google Scholar]
  9. Lidman K., Biberfeld G., Fagraeus A., Norberg R., Torstensson R., Utter G., Carlsson L., Luca J., Lindberg U. Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis. Clin Exp Immunol. 1976 May;24(2):266–272. [PMC free article] [PubMed] [Google Scholar]
  10. Lidman K., Eriksson U., Fagraeus A., Norberg R. Letter: Antibodies against thyroid cells in Yersinia enterocolitica infection. Lancet. 1974 Dec 14;2(7894):1449–1449. doi: 10.1016/s0140-6736(74)90102-0. [DOI] [PubMed] [Google Scholar]
  11. Linthicum D. S., Sell S. Surface immunoglobulin on rabbit lymphoid cells. I. Ultrastructural distribution and endocytosis of b4 allotypic determinants on peripheral blood lymphocytes. Cell Immunol. 1974 Jun;12(3):443–458. doi: 10.1016/0008-8749(74)90100-2. [DOI] [PubMed] [Google Scholar]
  12. NASTUK W. L., PLESCIA O. J., OSSERMAN K. E. Changes in serum complement activity in patients with myasthenia gravis. Proc Soc Exp Biol Med. 1960 Oct;105:177–184. doi: 10.3181/00379727-105-26050. [DOI] [PubMed] [Google Scholar]
  13. Osserman K. E., Genkins G. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med. 1971 Nov-Dec;38(6):497–537. [PubMed] [Google Scholar]
  14. Pollard T. D., Weihing R. R. Actin and myosin and cell movement. CRC Crit Rev Biochem. 1974 Jan;2(1):1–65. doi: 10.3109/10409237409105443. [DOI] [PubMed] [Google Scholar]
  15. Simpson J. A. Myasthenia gravis as an autoimmune disease: clinical aspects. Ann N Y Acad Sci. 1966 Jan 26;135(1):506–516. doi: 10.1111/j.1749-6632.1966.tb45499.x. [DOI] [PubMed] [Google Scholar]
  16. Smith B. R., Hall R. Thyroid-stimulating immunoglobulins in Graves' disease. Lancet. 1974 Aug 24;2(7878):427–431. doi: 10.1016/s0140-6736(74)91815-7. [DOI] [PubMed] [Google Scholar]
  17. Sutton R. N., Emond R. T., Thomas D. B., Doniach D. The occurrence of autoantibodies in infectious mononucleosis. Clin Exp Immunol. 1974 Jul;17(3):427–436. [PMC free article] [PubMed] [Google Scholar]
  18. Whittingham S., Mackay I. R., Kiss Z. S. An interplay of genetic and environmental factors in familial hepatitis and myasthenia gravis. Gut. 1970 Oct;11(10):811–816. doi: 10.1136/gut.11.10.811. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES